Bristol Myers Squibb has announced that the FDA has given approval to label updates for Breyanzi and Abecma to treat multiple ...

Cedars-Sinai investigators have developed an investigational therapy that brought a significant number of patients with ...

The Polish government’s new draft law on drug reimbursement aims to streamline procedures, empower patients, and ensure faster and more transparent access to essential therapies.

With CT scans picking up more cases of sclerosing mesenteritis, be prepared to diagnose this poorly understood autoimmune ...

Bristol Myers (BMY) receives FDA approval for label updates for Breyanzi and Abecma, that can ease access to the cancer cell ...